Pandemic response

A new Vaccine Development and Evaluation Centre (VDEC) has been unveiled in the UK, with the aim of building on the UK’s pandemic legacy and helping develop life-saving new vaccines that will fight ‘Disease X‘, a term used because what might trigger the next pandemic is unknown. The centre is situated at the UK Health […]

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this latest episode, DDW’s Megan Thomas is in conversation with Kate Kelland, author of Disease X: The 100 Days Mission to End Pandemics, which explores the emergence […]

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this latest episode, DDW’s Megan Thomas is in conversation with Kate Kelland, author of Disease X: The 100 Days Mission to End Pandemics, which explores the emergence […]

The University of Queensland is set to take a second-generation molecular clamp vaccine to a proof-of-concept human trial.  The Coalition for Epidemic Preparedness Innovation (CEPI) has committed up to AU$8.5 ($5.7) million to support further development of the re-engineered technology for use in the global response to future disease outbreaks.   Associate Professor Keith Chappell, co-leader […]

The Rockefeller Foundation will provide $3 million in new funding for Global.health (G.h) – an open-source platform for scientific pandemic data.  The investment will allow the platform to expand its international partnerships and modernise the global effort around coordinated pandemic prevention, surveillance, and response. Co-developed by researchers and engineers at the Department of Biology, University […]